Phycher Bio Développement participe au salon ASIATOX

Phycher attends ASIATOX 2018

18 May 2018

Find out more

Phycher bio développement témoin au TCELS

Thailand Life Sciences Business Forum

15 November 2017

Find out more

Congrès Biocides à Lyon

29 May 2017

Le règlement européen sur les produits biocides (UE) n°528/2012 fait suite à la directive européenne 98/8/CE visant à harmoniser la réglementation des États membres de l’Union européenne. L’objectif principal de cette réglementation est d’assurer un niveau de protection élevé de l’homme, des animaux et de l’environnement en limitant la mise à disposition sur le marché […]

Find out more

REACH: Regulatory evolution 

19 July 2016

  REACH requirements for skin corrosion/irritation, serious eye damage/eye irritation, acute dermal toxicity and skin sensitisation are changing, making non-animal testing the default requirement. ECHA reminds registrants of their obligations to consider and, where possible, use alternative methods. (UE) 2016/863 regulation has just been published : companies need to take the changed requirements into account […]

Find out more

Phycher a un agent commercial au Japon


19 July 2016

Japan is one of the leading economy in the world. As a full member of the OECD, Japan accepts Good Laboratory Practice tests. And, to extend our activity in Japan and be aware of the specificities of the market, Phycher is proud to introduce our new agent : Toyo Science Crop established in 1995 in Tokyo, […]

Find out more

Phycher labo

Phycher Bio Developpement is putting in place a new intramuscular implantation protocole

28 April 2016

The intramuscular implantation test is used to test the suitability of plastics and other polymers intended for use in fabricating containers and accessories thereto, for use in parenteral preparations, and for use in medical devices, implants and other systems. This test follows the U.S. Pharmacopeia: USP <88>: Biological reactivity tests in vivo. The test article is implanted […]

Find out more

Salon biocides

Biocides : Updating Active substances

18 April 2016

Several substances have just been approved: Biphényl-2-ol Implementation Regulation (UE) 2016/105 on 2016, January 27th, approved on 2017, July, 1st PHMB (1600; 1.8) Implementation Regulation (UE) 2016/124 and 125 on 2017, January 29th,  approved on 2017, July, 1st C(M)IT / MIT (3:1) Implementation Regulation (UE) 2016/131 on 2016, February 1st, approved on 2017, July, 1st […]

Find out more

Phycher est votre laboratoire de toxicologie

New partnership

3 February 2016

Our aim is your satisfaction. We are pleased to announce the signature of a new partnership with the Laboratory Lemi for the cytotoxicity, genotoxicity and hemocompatibility of Medical Devices. This partnership has the benefit of offering you more attractive prices. Phycher will remain your unique contact person for requests/offers/samples dispatch. Phycher will perform the in vivo studies: […]

Find out more

Impression et fabrication 3d des dispositifs médicaux par Phycher


10 December 2015

  2ACBI in collaboration with Phycher Bio Developpement organised a symposium on 3D medical devices manufacturing on November 23rd. Following themes have been discussed: –          Additive manufacturing at the service of health –          Additive manufacturing approach for an industrial –          Industrial issues to reach the next step of automatism prototype –          Bio impression: 3D impression […]

Find out more

New Test : OECD 492

1 October 2015

Phycher is now offering the new OECD 492. This test is an in vitro eye irritation test on reconstructed human Cornea-like Epithelium (RhCE) test method to identify chemicals not requiring classification and labelling for eye irritation or serious eye damage. For more information, please click here. 

Find out more

We call you back